Nektar TherapeuticsNKTRNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Loading chart...

Alerts

Want to monitor NKTR?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor NKTR

Key Statistics

About

nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

CEO

Howard Robin

nektar.com/ →

DEADLINE ALERT for ITGR, FFIV, SLM, and KLAR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

globenewswire.com

Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates

globenewswire.com

Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates

globenewswire.com

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

Key Statistics

About

News

FFIV Investors Have Opportunity to Lead F5, Inc. Securities Fraud Lawsuit with the Schall Law Firm

AstraZeneca begins trading directly on the NYSE

Vanguard Mining Reports Re-Assay Program for Redonda Copper-Molybdenum Project

Giant Mining Plans Up to 10,000-Foot Multi-Phase Drill Program at Majuba Hill Copper-Silver Project, Nevada

DEADLINE ALERT for ITGR, FFIV, SLM, and KLAR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

DeepMarkit Strengthens Governance Expertise with Appointment of Lanre Okunnuga as Strategic Advisor

Record January fuel oil exports from Kuwait's al-Zour refinery weigh on Asian market

21shares Appoints Stephen Coltman as Head of Macro to Strengthen Investment Team

Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates

Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates

AMD Vs. Intel: AMD Takes The Lead In 2026

Jonathan Dale Joins Evercore as Senior Managing Director in the Consumer Group

Palantir Faces Lofty Expectations Heading Into Earnings

NCR Atleos and Heart of England Co-operative Extend Relationship to Enhance Financial Inclusion

Natural Gas and Oil Forecast: Is Oil Done Falling at $61 or Just Pausing Before $60?

Meta Platform Shares Jump on Strong Outlook. Can the Stock's Momentum Continue?

3 Stocks to Buy in February

Should Investors Buy Tesla Stock After Upbeat Outlook on Robotaxis and Robots?

Nebius Group N.V. Announces Date of Fourth Quarter and Full Year 2025 Results and Conference Call

Auction Technology Group suitor FitzWalter Capital walks away

Explore More

FFIV Investors Have Opportunity to Lead F5, Inc. Securities Fraud Lawsuit with the Schall Law Firm

AstraZeneca begins trading directly on the NYSE

Vanguard Mining Reports Re-Assay Program for Redonda Copper-Molybdenum Project

Giant Mining Plans Up to 10,000-Foot Multi-Phase Drill Program at Majuba Hill Copper-Silver Project, Nevada

DEADLINE ALERT for ITGR, FFIV, SLM, and KLAR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

DeepMarkit Strengthens Governance Expertise with Appointment of Lanre Okunnuga as Strategic Advisor

Record January fuel oil exports from Kuwait's al-Zour refinery weigh on Asian market

21shares Appoints Stephen Coltman as Head of Macro to Strengthen Investment Team

Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates

Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates

AMD Vs. Intel: AMD Takes The Lead In 2026

Jonathan Dale Joins Evercore as Senior Managing Director in the Consumer Group

Palantir Faces Lofty Expectations Heading Into Earnings

NCR Atleos and Heart of England Co-operative Extend Relationship to Enhance Financial Inclusion

Natural Gas and Oil Forecast: Is Oil Done Falling at $61 or Just Pausing Before $60?

Meta Platform Shares Jump on Strong Outlook. Can the Stock's Momentum Continue?

3 Stocks to Buy in February

Should Investors Buy Tesla Stock After Upbeat Outlook on Robotaxis and Robots?

Nebius Group N.V. Announces Date of Fourth Quarter and Full Year 2025 Results and Conference Call

Auction Technology Group suitor FitzWalter Capital walks away

Key Statistics